PDS Biotechnology (PDSB) Tops Q2 EPS by 8c

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.20), $0.08 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Darling Ingredients (DAR) PT Raised to $88 at UBS
• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue